{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:58:01Z","timestamp":1786121881559,"version":"build-2736575974"},"reference-count":20,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study assessed the efficacy and safety of a triple fixed\u2010dose combination (FDC) of sitagliptin, metformin, and glimepiride versus co\u2010administered metformin and glimepiride in Indian patients with uncontrolled Type 2 diabetes (T2D).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>\n                      In this Phase 3, randomised, double\u2010blind, double\u2010dummy study, adult patients with T2D and glycated haemoglobin (HbA\n                      <jats:sub>1c<\/jats:sub>\n                      ) of 8%\u201311%, despite treatment with metformin and glimepiride, were randomised 1:1 to triple FDC of sitagliptin 50\u2009mg, metformin 1000\u2009mg and glimepiride 1\u2009mg (SITA\u2009+\u2009MET\u2009+\u2009GLIM group) or metformin 1000\u2009mg and glimepiride 2\u2009mg (Co\u2010administration group) for 16\u2009weeks. Patients assigned to the SITA\u2009+\u2009MET\u2009+\u2009GLIM group could continue treatment for a 12\u2010week open\u2010label period. The primary endpoint was the change in HbA\n                      <jats:sub>1c<\/jats:sub>\n                      from baseline to Week 16.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 190 patients were randomised to the SITA\u2009+\u2009MET\u2009+\u2009GLIM group and 202 to the Co\u2010administration group. The least squares mean (standard error) change from baseline in HbA\n                      <jats:sub>1c<\/jats:sub>\n                      at Week 16 was \u22121.79 (0.07%) in the SITA\u2009+\u2009MET\u2009+\u2009GLIM group and \u22121.27 (0.06%) in the co\u2010administration group (estimated treatment difference \u22120.51; 95% confidence interval [CI] \u22120.69 to \u22120.33;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). The proportion of patients with HbA\n                      <jats:sub>1c<\/jats:sub>\n                      below 7% at Week 16 was 32.1% in the SITA\u2009+\u2009MET\u2009+\u2009GLIM group and 12.6% in the Co\u2010administration group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Adverse events occurred in 25 patients (13.2%) in the SITA\u2009+\u2009MET\u2009+\u2009GLIM group and 30 patients (14.9%) in the Co\u2010administration group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The triple FDC was superior to co\u2010administered metformin and high\u2010dose glimepiride for achieving glycaemic control and was well tolerated in Indian patients with T2D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      Clinical Trials Registry\u2013India identifier: CTRI\/2021\/11\/038169 (registered on 22 November 2021); URL:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?EncHid=NjI1Mjk=&amp;Enc=&amp;userName=\">https:\/\/www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?EncHid=NjI1Mjk=&amp;Enc=&amp;userName=<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.70778","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:11:01Z","timestamp":1777853461000},"page":"6207-6216","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sitagliptin, Metformin and Glimepiride Fixed\u2010Dose Combination Compared to Co\u2010Administration of Metformin and High\u2010Dose Glimepiride in Indian Patients With Type 2 Diabetes: A Randomised, Double\u2010Blind, Double\u2010Dummy, Phase 3 Clinical Study"],"prefix":"10.1111","volume":"28","author":[{"given":"Rakesh","family":"Sahay","sequence":"first","affiliation":[{"name":"Department of Endocrinology Osmania General Hospital  Hyderabad Telangana India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambanna","family":"Gowda","sequence":"additional","affiliation":[{"name":"Citizen Hospital  Bengaluru Karnataka India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish Kumar","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Medicine Maya Hospital and Maternity Centre  Kanpur Uttar Pradesh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Gopal","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Medicine Government Medical College and Government General Hospital  Srikakulam Andhra Pradesh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Duraisamy","sequence":"additional","affiliation":[{"name":"Department of Diabetology Kovai Diabetes Speciality Centre and Hospital  Coimbatore Tamil Nadu India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Gangwani","sequence":"additional","affiliation":[{"name":"Department of Medicine Priyadarshani Nursing Home  Virar Maharashtra India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Shukla","sequence":"additional","affiliation":[{"name":"Department of Medicine Moti Lal Nehru Medical College  Prayagraj Uttar Pradesh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Medicine Surya Super Speciality Hospital  Varanasi Uttar Pradesh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandesh Sahebarao","family":"Patil","sequence":"additional","affiliation":[{"name":"Department of Medicine Shree Siddhivinayak Maternity and Nursing Home  Maharashtra India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrish","family":"C.","sequence":"additional","affiliation":[{"name":"Department of Diabetology Medstar Speciality Hospital  Bengaluru Karnataka India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish Babu","family":"K. N.","sequence":"additional","affiliation":[{"name":"Sparsh Super Speciality Hospital  Bengaluru Karnataka India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Palawat","sequence":"additional","affiliation":[{"name":"Department of Medicine Sawai Man Singh Medical College and Attached Hospitals  Jaipur Rajasthan India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip Krishnrao","family":"Gofne","sequence":"additional","affiliation":[{"name":"Department of Medicine District Civil Hospital  Aurangabad Maharashtra India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay Kumar","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism Institute of Medical Sciences and Sum Hospital  Bhubaneswar Odisha India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep Kumar","family":"Rai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Nephrology Opal Hospital Private Limited  Varanasi Uttar Pradesh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raisa","family":"Shaikh","sequence":"additional","affiliation":[{"name":"Medical Affairs and Clinical Research Sun Pharma Laboratories Limited  Mumbai Maharashtra India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Saha","sequence":"additional","affiliation":[{"name":"Medical Affairs and Clinical Research Sun Pharma Laboratories Limited  Mumbai Maharashtra India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8690-3302","authenticated-orcid":false,"given":"Dipak","family":"Patil","sequence":"additional","affiliation":[{"name":"Medical Affairs and Clinical Research Sun Pharma Laboratories Limited  Mumbai Maharashtra India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Ghadge","sequence":"additional","affiliation":[{"name":"Medical Affairs and Clinical Research Sun Pharma Laboratories Limited  Mumbai Maharashtra India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Patel","sequence":"additional","affiliation":[{"name":"Medical Affairs and Clinical Research Sun Pharma Laboratories Limited  Mumbai Maharashtra India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Lakhwani","sequence":"additional","affiliation":[{"name":"Medical Affairs and Clinical Research Sun Pharma Laboratories Limited  Mumbai Maharashtra India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyog","family":"Mehta","sequence":"additional","affiliation":[{"name":"Medical Affairs and Clinical Research Sun Pharma Laboratories Limited  Mumbai Maharashtra India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhna","family":"Joglekar","sequence":"additional","affiliation":[{"name":"Medical Affairs and Clinical Research Sun Pharma Laboratories Limited  Mumbai Maharashtra India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,3]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(23)00119-5"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.4103\/JOD.JOD_100_20"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1988.tb01003.x"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32131-2"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2112"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00072-9"},{"key":"e_1_2_10_8_1","article-title":"Assessment of Medication Adherence and Associated Factors Among Patients With Diabetes Attending a Non\u2010Communicable Disease Clinic in a Community Health Centre in Eastern India","volume":"15","author":"Mishra A.","year":"2023","journal-title":"Cureus"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0034"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1156081"},{"key":"e_1_2_10_11_1","unstructured":"United States Food and Drug Administration \u201cGLUCOPHAGE Prescribing Information \u201d2018 accessed 25 May 2025 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/020357s034 021202s018lbl.pdf."},{"key":"e_1_2_10_12_1","unstructured":"United States Food and Drug Administration \u201cJANUVIA Prescribing Information \u201d2023 accessed 25 May 2025 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/021995Orig1s053lbl.pdf."},{"key":"e_1_2_10_13_1","unstructured":"United States Food and Drug Administration \u201cAMARYL Prescribing Information \u201d2018 accessed 25 May 2025 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/020496s029lbl.pdf."},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.4103\/cdrp.cdrp_5_22"},{"key":"e_1_2_10_15_1","first-page":"127","article-title":"Efficacy of Combination Therapy With Sitagliptin and Low\u2010Dose Glimepiride in Japanese Patients With Type 2 Diabetes","volume":"6","author":"Ishii H.","year":"2014","journal-title":"Journal of Clinical Medicine Research"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr3632"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ14-0233"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ11-0064"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2007.00744.x"},{"key":"e_1_2_10_20_1","unstructured":"E.\u2010O. K.EB B.Zethelius A. M.Svensson S.Gudbjornsd\u00f3ttir andJ.Cederholm \u201cHbA1c Reduction and Risk of Cardiovascular Diseases in Type 2 Diabetes: An Observational Study From the Swedish NDR. 72nd Scientific Sessions of the American Diabetes Association \u201dJune 8\u201312 2012 Philadelphia Pennsylvania USA Abstract 415\u2010P."},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13410-023-01192-6"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.70778","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.70778","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.70778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T07:34:43Z","timestamp":1786088083000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/10.1111\/dom.70778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,3]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1111\/dom.70778"],"URL":"https:\/\/doi.org\/10.1111\/dom.70778","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.70778\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70778\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70778\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70778\/v2\/decision1","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,3]]},"assertion":[{"value":"2026-03-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}